EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Reprogramming of the lipid metabolism axis in systemic sclerosis: mechanism analysis and therapeutic potential

Rong-Hong Guo, Xian-Zhe Zhou, Yan-Li Yang, Jia-Xin Chen, Jin-Fang Gao, Ke Xu

Clinical Rheumatology · 2026-08 · 45 (8) · 4735-4745

DOI: 10.1007/s10067-026-08189-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Rheumatology, online erschienen am 30.05.2026. Verfasst von Rong-Hong Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, Ch…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Lipid Metabolism, Dyslipidemias. Die Arbeit nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc), a highly fatal autoimmune disease, is characterized by pathological hallmarks including microvascular damage, immune dysregulation, and progressive fibrosis affecting the skin and multiple organs. Clinically, SSc-related interstitial lung disease and cardiovascular complications represent the primary causes of mortality. Emerging research has highlighted the role of lipid metabolism dysregulation in SSc pathogenesis, with clinically observed abnormal lipid profiles potentially linked to disease progression. Advances in lipidomics have elucidated pathological alterations in specific lipid species and their signaling pathways, offering novel insights into metabolic reprogramming in SSc and identifying potential therapeutic targets. This review synthesizes current evidence on lipid abnormalities in SSc patients, focusing on the interplay between dyslipidemia and three core pathological processes: vascular injury, immune dysfunction, and fibrotic remodeling. Additionally, we briefly analyze the effects of existing drug interventions on the lipid profile of SSc patients, providing a foundation for developing lipid metabolism-targeted therapies to refine clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicLipid MetabolismDyslipidemiasHumansFibrosisSignal TransductionAnimals

Stichwörter der Autor:innen

FibrosisImmunityLipid metabolismMetabolic reprogrammingSystemic sclerosis

Autor:innen und Institutionen

  • Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
  • Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China. xuke@sxbqeh.com.cn.

Zitieren

APA

Guo, R. H., Zhou, X. Z., Yang, Y. L., Chen, J. X., Gao, J. F., & Xu, K. (2026). Reprogramming of the lipid metabolism axis in systemic sclerosis: mechanism analysis and therapeutic potential. Clinical Rheumatology, 45(8), 4735-4745. https://doi.org/10.1007/s10067-026-08189-6

Vancouver

Guo RH, Zhou XZ, Yang YL, Chen JX, Gao JF, Xu K. Reprogramming of the lipid metabolism axis in systemic sclerosis: mechanism analysis and therapeutic potential. Clinical Rheumatology. 2026;45(8):4735-4745. doi:10.1007/s10067-026-08189-6

BibTeX
@article{Guo2026,
  author = {Guo, Rong-Hong and Zhou, Xian-Zhe and Yang, Yan-Li and Chen, Jia-Xin and Gao, Jin-Fang and Xu, Ke},
  title = {Reprogramming of the lipid metabolism axis in systemic sclerosis: mechanism analysis and therapeutic potential},
  journal = {Clinical Rheumatology},
  year = {2026},
  volume = {45},
  number = {8},
  pages = {4735--4745},
  doi = {10.1007/s10067-026-08189-6}
}
Kostenlos starten →